IP Library Granted Patent US 9,326,716
Granted Patent B2
US 9,326,716 · App. 14/562,625 · Granted May 3, 2016

Analyte monitoring device and methods of use

Inventors: Adam Heller (Austin, TX); Benjamin Jay Feldman (Berkeley, CA); Shridhara Alva Karinka (Pleasanton, CA); Yi Wang (San Ramon, CA); John R. Galasso (Saint Helena, CA)
Assignee: Abbott Diabetes Care Inc.
A61B5/1495A61B5/1451A61B5/1473A61B5/1477A61B5/14532A61B5/14542A61B5/14546A61B5/14865A61B5/7445G01N27/3272G01N27/3273A61B2562/0295
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,326,716
App. No.
14/562,625
Granted
May 3, 2016
Kind
B2
Abstract

In aspects of the present disclosure, a no coding blood glucose monitoring unit including a calibration unit is integrated with one or more components of an analyte monitoring system to provide compatibility with in vitro test strip that do not require a calibration code is provided. Also disclosed are methods, systems, devices and kits for providing the same.

Claims (21)

1. An apparatus, comprising:

an analyte sensor interface configured to receive an in vitro analyte sensor, wherein the in vitro analyte sensor generates an analyte signal from a fluid sample; and

a processor operatively coupled to a data receiver and the analyte sensor interface, the processor configured to recognize the in vitro analyte sensor without a user input when the in vitro analyte sensor is received in the analyte sensor interface and is a no-coding in vitro analyte sensor, and to retrieve a universal calibration parameter when the recognized in vitro analyte sensor is the no-coding in vitro analyte sensor.

2. The apparatus of claim 1 , wherein the analyte sensor interface comprises a first contact structure and a second contact structure configured to contact the in vitro analyte sensor.

3. The apparatus of claim 1 , wherein the in vitro analyte sensor is a calibration-adjusted in vitro analyte sensor.

4. The apparatus of claim 1 , wherein the universal calibration parameter is stored in a memory operatively coupled to the processor, and includes a universal calibration code.

5. The apparatus of claim 4 , wherein the universal calibration parameter stored in the memory is a standard calibration code, and the in vitro analyte sensor is manufactured to fit the standard calibration code.

6. The apparatus of claim 1 , further including a data receiver operatively coupled to the processor and configured to receive data relating to analyte levels from an analyte sensor in fluid contact with interstitial fluid.

7. The apparatus of claim 6 , wherein the analyte sensor comprises a plurality of electrodes including a working electrode, wherein the working electrode comprises an analyte-responsive enzyme and a mediator, and wherein at least one of the analyte-responsive enzyme and the mediator is chemically bonded to a polymer disposed on the working electrode.

8. The apparatus of claim 7 , wherein the at least one of the analyte-responsive enzyme and the mediator is crosslinked with the polymer.

9. The apparatus of claim 1 , wherein the universal calibration parameter is a standard calibration code, and the in vitro analyte sensor is manufactured to fit the standard calibration code.

10. The apparatus of claim 6 , wherein the analyte sensor is configured to monitor one or more of a glucose level, lactate level, or oxygen level.

11. An apparatus, comprising:

an in vitro analyte sensor interface;

one or more processors operatively coupled to the in vitro analyte sensor interface; and

a memory operatively coupled to the one or more processors, the memory for storing instructions which, when executed by the one or more processors, causes the one or more processors to determine a type of in vitro analyte sensor received at the in vitro analyte sensor interface, to determine the type of in vitro analyte sensor without a user input when the in vitro analyte sensor is a no-coding in vitro analyte sensor, and to process one or more signals generated by the in vitro analyte sensor with a universal calibration parameter when the determined type of in vitro analyte sensor is the no-coding in vitro analyte sensor, wherein the universal calibration parameter is associated with in vitro analyte sensors that are no-coding in vitro analyte sensors.

12. The apparatus of claim 11 , wherein the memory for storing instructions which, when executed by the one or more processors, causes the one or more processors to automatically calibrate the one or more signals generated by the in vitro analyte sensor based on the universal calibration parameter without user interaction when the type of in vitro analyte sensor is determined.

13. The apparatus of claim 11 , wherein the memory for storing instructions which, when executed by the one or more processors, causes the one or more processors to receive and process a plurality of time spaced signals from sensor electronics operatively coupled to an analyte sensor configured to monitor an analyte level in interstitial fluid.

14. The apparatus of claim 13 , wherein the analyte sensor includes a plurality of electrodes, wherein the plurality of electrodes include a working electrode, wherein the working electrode comprises an analyte-responsive enzyme and a mediator, and wherein at least one of the analyte-responsive enzyme and the mediator is chemically bonded to a polymer disposed on the working electrode.

15. The apparatus of claim 14 , wherein the at least one of the analyte-responsive enzyme and the mediator is crosslinked with the polymer.

16. The apparatus of claim 11 , wherein the universal calibration parameter stored in the memory is a standard calibration code, and the in vitro analyte sensor is manufactured to fit the standard calibration code.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 8, 2014
From: HELLER, ADAM; FELDMAN, BENJAMIN JAY; KARINKA, SHRIDHARA ALVA; WANG, YI; GALASSO, JOHN R.
To: ABBOTT DIABETES CARE INC.
Reel/Frame 034428/0132 →
Continuity (4)
Continuation 14229520 · Mar 28, 2014
Continuation 12495798 · Jun 30, 2009
Continuation In Part 11265787 · Nov 1, 2005
Related Publication 20150094553A1 · Apr 2, 2015